Novel alternative ribonucleotide excision repair pathways in human cells by DDX3X and specialized DNA polymerases

© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research..

Removal of ribonucleotides (rNMPs) incorporated into the genome by the ribonucleotide excision repair (RER) is essential to avoid genetic instability. In eukaryotes, the RNaseH2 is the only known enzyme able to incise 5' of the rNMP, starting the RER process, which is subsequently carried out by replicative DNA polymerases (Pols) δ or ϵ, together with Flap endonuclease 1 (Fen-1) and DNA ligase 1. Here, we show that the DEAD-box RNA helicase DDX3X has RNaseH2-like activity and can support fully reconstituted in vitro RER reactions, not only with Pol δ but also with the repair Pols β and λ. Silencing of DDX3X causes accumulation of rNMPs in the cellular genome. These results support the existence of alternative RER pathways conferring high flexibility to human cells in responding to the threat posed by rNMPs incorporation.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:48

Enthalten in:

Nucleic acids research - 48(2020), 20 vom: 18. Nov., Seite 11551-11565

Sprache:

Englisch

Beteiligte Personen:

Riva, Valentina [VerfasserIn]
Garbelli, Anna [VerfasserIn]
Casiraghi, Federica [VerfasserIn]
Arena, Francesca [VerfasserIn]
Trivisani, Claudia Immacolata [VerfasserIn]
Gagliardi, Assunta [VerfasserIn]
Bini, Luca [VerfasserIn]
Schroeder, Martina [VerfasserIn]
Maffia, Antonio [VerfasserIn]
Sabbioneda, Simone [VerfasserIn]
Maga, Giovanni [VerfasserIn]

Links:

Volltext

Themen:

8L70Q75FXE
Adenosine Triphosphate
DDX3X protein, human
DEAD-box RNA Helicases
DNA Polymerase beta
DNA polymerase beta2
EC 2.7.7.-
EC 2.7.7.7
EC 3.1.26.-
EC 3.1.26.4
EC 3.6.1.-
EC 3.6.4.13
Journal Article
Research Support, Non-U.S. Gov't
Ribonuclease H
Ribonuclease HII
Ribonucleotides

Anmerkungen:

Date Completed 03.02.2021

Date Revised 03.02.2021

published: Print

Citation Status MEDLINE

doi:

10.1093/nar/gkaa948

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM317055364